Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable
Rheumatology Feb 02, 2018
Devauchelle-Pensec V, et al. - The researchers herein, aimed to develop substitutes to the polymyalgia rheumatica activity score (PMR-AS) that did not require C-reactive protein (CRP). Findings revealed that in patients without available CRP values and in those receiving IL-6 antagonist therapy, substitutes of PMR-AS obtained without CRP could be used to monitor PMR activity in routine practice.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
